Key Highlights: Implications: Gland Pharma’s move to acquire Gland Pharma USA Inc. directly from its Singapore intermediate holding company is a purely internal restructuring that removes ...
Key Highlights: Implications: For Novartis India, bringing these brands back in‑house supports a more controlled go‑to‑market under new PE ownership and aligns with its plan to insta...
Key Highlights: Implications: By embedding dynamic QR codes and invoice-linked payment links with automatic bill‑by‑bill reconciliation, the solution can materially cut cash handling, spee...
